The National Institute for Health and Care Excellence (NICE) has recommended Blueprint Medicines’ Ayvakyt (avapritinib) to ...

The announcement comes just a few months after WHO released its 2024 Bacterial Priority Pathogens List, which highlights the ...

A UK study has demonstrated that interventions to reduce respiratory syncytial virus (RSV) infections could help to reduce ...

The companies will use Ascendis’ TransCon technology to develop therapies for metabolic and cardiovascular diseases ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission (EC) to treat eosinophilic ...

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ ...

EXECUTIVE FACILITIES established for over 30 years is a ‘specialist’ recruitment consultancy run by ‘recruitment specialists’. Our highly trained Consultants, educated to degree level, have expert ...

The US Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi (minocycline hydrochloride extended release capsules 40mg) to treat inflammatory lesions of rosacea in adults. Affecting ...

Principal Medical Writer, Dr Alexandra Loveday explores the importance of storytelling in health communications. Medical facts alone don’t change minds—stories do. Originating from the broader ...

GSK has announced that it will be expanding its immunology pipeline by acquiring a clinical-stage T cell-engager from Chimagen Biosciences in a deal worth $850m. GSK said it plans to develop and ...

UCB has announced “encouraging data” from a phase 2a study of its investigational anti-tau antibody bepranemab in Alzheimer’s disease (AD) patients. The TOGETHER study has been evaluating the safety, ...

EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to ...